"You have these drugs that both activate brain stem neurons to tell you you're full and silence AgRP neurons that should then become active and tell your brain, 'you need to eat, you are losing weight ...

The FDA on Monday approved a daily pill version of Novo Nordisk’s Wegovy, making it the first oral GLP-1 obesity treatment ...

A new study uses shopping receipts to show how appetite changes from Ozempic and Wegovy affect grocery and restaurant ...

Drugs like Ozempic, Wegovy and Zepbound have transformed how we treat obesity, but more effective treatments could be down ...

A newly discovered protein “sidekick” may explain why appetite control works for some people and fails for others.

In early studies, a new drug under investigation called eloralintide helped some adults lose nearly 50 pounds in under a year — and it’s not a GLP-1. Eloralintide is an experimental obesity drug that ...

GLP-1 weight-loss drugs such as tirzepatide are known to curb appetite, but effects on out-of-control eating are less understood Brain studies of a woman who battled obesity and obsessive eating found ...

Scientists in Sweden have created a new pill designed to help the body burn fat and control blood sugar in a different way than popular GLP-1 drugs, like Ozempic. While injectable GLP-1s work by ...

After months of rigorous testing and analysis throughout 2025-2026, we are excited to present the most comprehensive review ...